4nh9
From Proteopedia
(Difference between revisions)
												
			
			| Line 1: | Line 1: | ||
| - | + | {{STRUCTURE_4nh9|  PDB=4nh9  |  SCENE=  }}  | |
| + | ===Correlation between chemotype-dependent binding conformations of HSP90 alpha/beta and isoform selectivity=== | ||
| + | {{ABSTRACT_PUBMED_24332488}} | ||
| - | + | ==Function== | |
| + | [[http://www.uniprot.org/uniprot/ENPL_HUMAN ENPL_HUMAN]] Molecular chaperone that functions in the processing and transport of secreted proteins. When associated with CNPY3, required for proper folding of Toll-like receptors (By similarity). Functions in endoplasmic reticulum associated degradation (ERAD). Has ATPase activity.<ref>PMID:18264092</ref>   | ||
| - | + | ==About this Structure== | |
| + | [[4nh9]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4NH9 OCA].  | ||
| - | + | ==Reference== | |
| + | <ref group="xtra">PMID:024332488</ref><references group="xtra"/><references/> | ||
| + | [[Category: Ernst, J T.]] | ||
| + | [[Category: Zuccola, H J.]] | ||
| + | [[Category: A/b structure]] | ||
| + | [[Category: Chaperone]] | ||
| + | [[Category: Endoplasmic reticulum]] | ||
Revision as of 06:58, 22 January 2014
| Contents | 
Correlation between chemotype-dependent binding conformations of HSP90 alpha/beta and isoform selectivity
Template:ABSTRACT PUBMED 24332488
Function
[ENPL_HUMAN] Molecular chaperone that functions in the processing and transport of secreted proteins. When associated with CNPY3, required for proper folding of Toll-like receptors (By similarity). Functions in endoplasmic reticulum associated degradation (ERAD). Has ATPase activity.[1]
About this Structure
4nh9 is a 1 chain structure. Full crystallographic information is available from OCA.
Reference
- Ernst JT, Liu M, Zuccola H, Neubert T, Beaumont K, Turnbull A, Kallel A, Vought B, Stamos D. Correlation between chemotype-dependent binding conformations of HSP90alpha/beta and isoform selectivity-Implications for the structure-based design of HSP90alpha/beta selective inhibitors for treating neurodegenerative diseases. Bioorg Med Chem Lett. 2014 Jan 1;24(1):204-8. doi: 10.1016/j.bmcl.2013.11.036., Epub 2013 Nov 23. PMID:24332488 doi:http://dx.doi.org/10.1016/j.bmcl.2013.11.036
- ↑ Christianson JC, Shaler TA, Tyler RE, Kopito RR. OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD. Nat Cell Biol. 2008 Mar;10(3):272-82. doi: 10.1038/ncb1689. Epub 2008 Feb 10. PMID:18264092 doi:http://dx.doi.org/10.1038/ncb1689
